DK155668B - METHOD FOR PREPARING 2,4-DIAMINO-5- (3 ', 4', 5'-TRIMETHOXYBENZYL) -PYRIMIDINE - Google Patents

METHOD FOR PREPARING 2,4-DIAMINO-5- (3 ', 4', 5'-TRIMETHOXYBENZYL) -PYRIMIDINE Download PDF

Info

Publication number
DK155668B
DK155668B DK275682A DK275682A DK155668B DK 155668 B DK155668 B DK 155668B DK 275682 A DK275682 A DK 275682A DK 275682 A DK275682 A DK 275682A DK 155668 B DK155668 B DK 155668B
Authority
DK
Denmark
Prior art keywords
formula
trimethoxybenzyl
guanidine
diethylene glycol
diamino
Prior art date
Application number
DK275682A
Other languages
Danish (da)
Other versions
DK155668C (en
DK275682A (en
Inventor
Ivan Beck
Irme Biro
Andras Dietz
Elemer Jakfalvi
Laszlo Ladanyi
Istvan Simonyi
Zoltan Takacs
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of DK275682A publication Critical patent/DK275682A/en
Publication of DK155668B publication Critical patent/DK155668B/en
Application granted granted Critical
Publication of DK155668C publication Critical patent/DK155668C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Description

1 DK 155668 B1 DK 155668 B

OISLAND

Den foreliggende opfindelse angår en særlig fremgangsmåde til fremstilling af 2,4-diamino-5-(3,,4,,5,-tri-methoxybenzyl)-pyrimidiner med formlen CELO NH0 5 CHqO-/ ' .-CH, - V.-NH- (X)The present invention relates to a particular process for the preparation of 2,4-diamino-5- (3,4,4,5,5-tri-methoxybenzyl) -pyrimidines of the formula CELO NHO 5 CH 2 O- / CH-V. -NH- (X)

3 V/ 2 W3 V / 2 W

οά/ 10 ved omsætning af en a- (3,4,5-trimethoxybenzyl)-β-(substitueret) -acrylonitril med guanidin.οά / 10 by reacting an α- (3,4,5-trimethoxybenzyl) -β- (substituted) acrylonitrile with guanidine.

2,4-Diamino-5- (31,41,51-trimethoxybenzyl)-pyrimi-dinen, kendt som trimethoprim, er et værdifuldt farmaceutisk præparat med meget kraftig antibakteriel virkning.2,4-Diamino-5- (31,41,51-trimethoxybenzyl) -pyrimidine, known as trimethoprim, is a valuable pharmaceutical composition with very potent antibacterial activity.

15 Der har været beskrevet adskillige fremgangsmåder til fremstilling af trimethoprim, hvoraf en del gennemføres ved anvendelse af a-(3,4,5-trimethoxybenzyl)-β-(substitueret) -acrylonitril.Several methods have been described for the preparation of trimethoprim, part of which is carried out using α- (3,4,5-trimethoxybenzyl) -β- (substituted) acrylonitrile.

Således kondenseres ifølge GB patentskrift nr.Thus, according to GB patent specification no.

20 957.797 3,4,5-trimethoxybenzaldehyd med β-alkoxypropio- nitril til fremstilling af et kondensationsprodukt i et udbytte på over 80%. Reaktionsproduktet består af ca. 80% a-(3,4,5-trimethoxybenzal)-β-alkoxy-acrylonitril og ca.20 957.797 3,4,5-trimethoxybenzaldehyde with β-alkoxypropionitrile to produce a condensation product in a yield of over 80%. The reaction product consists of approx. 80% α- (3,4,5-trimethoxybenzal) -β-alkoxy-acrylonitrile and approx.

20% a-(3,4,5-trimethoxybenzyl)-β-alkoxyacrylonitril. I det 25 efterfølgende trin cycliseres kondensationsproduktet med guanidin. Imidlertid tager kun "benzyl"-forbindelsen del i ringslutningsreaktionen, medens der praktisk taget ikke sker nogen isomerisering af "benzal"-forbindelsen til "benzyl"-forbindelsen. Som følge heraf kan der ikke fås 30 et udbytte af trimethoprim, der overstiger 28%, dvs. at det samlede udbytte, beregnet for 3,4,5-trimethoxybenzaldehyd svarer til højst 20-24%.20% α- (3,4,5-trimethoxybenzyl) -β-alkoxyacrylonitrile. In the subsequent step, the condensation product is cyclized with guanidine. However, only the "benzyl" compound participates in the cyclization reaction, while practically no isomerization of the "benzal" compound to the "benzyl" compound. As a result, a yield of trimethoprim exceeding 28% cannot be obtained, i.e. the total yield calculated for 3,4,5-trimethoxybenzaldehyde is no more than 20-24%.

Ifølge GB patentskrift nr. 1.261.455 omsættes kondensationsproduktet af 3,4,5-trimethoxybenzaldehyd og β-35 -alkoxypropionitril med en amin, hvorved der fås a- (3,4,5-According to GB Patent No. 1,261,455, the condensation product of 3,4,5-trimethoxybenzaldehyde and β-35-alkoxypropionitrile is reacted with an amine to give α- (3,4,5-

2 DK 155668 B2 DK 155668 B

OISLAND

-trimethoxybenzal) -β-aminopropionitril, som kan isomeriseres til den tilsvarende "benzyl"-isomer i et udbytte på 40-50%. Sidstnævnte isomer kan cycliseres med guanidin, hvorved fås trimethoprim i et udbytte på 80%. Imidlertid 5 er det samlede udbytte af trimethoprim, beregnet for 3.4.5- trimethoxybenzaldehyd, selv ved denne fremgangsmåde, lavere end 40%.-trimethoxybenzal) -β-aminopropionitrile, which can be isomerized to the corresponding "benzyl" isomer in a 40-50% yield. The latter isomer can be cyclized with guanidine to give trimethoprim in 80% yield. However, the overall yield of trimethoprim, calculated for 3.4.5-trimethoxybenzaldehyde, even by this method is lower than 40%.

Ifølge GB patentskrift nr. 1.554.493 omsættes 3.4.5- trimethoxybenzaldehyd med en β-(2-alkoxy-ethoxy)-10 -propionitril, hvorved der fås a-(31,4',5'-trimethoxybenzal) -β-(2-alkoxyethoxy)-pripionitril i et udbytte på mere end 80%. Efter fraskillelse og omhyggelig rensning isomeriseres denne forbindelse til den tilsvarende "benz-yl"-isomer i nærværelse af en base ved en temperatur i 15 området 90-95°C. "Benzyl"-isomeren omsættes med guanidin, hvorved der fås trimethoprim i et udbytte på ca. 80%.According to GB Patent No. 1,554,493, 3.4.5-trimethoxybenzaldehyde is reacted with a β- (2-alkoxy-ethoxy) -10-propionitrile to give α- (31,4 ', 5'-trimethoxybenzal) -β- ( 2-alkoxyethoxy) -pripionitrile in a yield of more than 80%. After separation and careful purification, this compound is isomerized to the corresponding "benzyl" isomer in the presence of a base at a temperature in the range 90-95 ° C. The "benzyl" isomer is reacted with guanidine to give trimethoprim in a yield of ca. 80%.

Det samlede udbytte er således 64-72% efter laboratorie-målestok.Thus, the overall yield is 64-72% by laboratory scale.

Selv om den sidst beskrevne fremgangsmåde faktisk 20 er mere økonomisk end de tidligere, opstår der nogle vanskeligheder, når den anvendes på fabriksplan. Det ved kondensationsreaktionen af 3,4,5-trimethoxybenzaldehyd og β--(2-alkoxyethoxy)-propionitril dannede vand afdestilleres ved høj temperatur, f.eks. ca. 120°C. Ved en sådan høj temperatur 25 hydrolyseres a-(3,4,5-trimethoxybenzal)-β-(2-alkoxyethoxy)- propionitrilen af det tilstedeværende vand. Det har nu ifølge opfindelsen vist sig, at hydrolysen af nitrilgruppen sker som en sideløbende reaktion, og der fremstilles den tilsvarende carboxylsyre. Ved denne reaktion dannes der tjæreagtige bipro-30 dukter. Mængden heraf forøges ved anvendelse af større batch--mængder. Således bliver det efter laboratoriemålestok opnåede totaludbytte på 64-72% så lavt som 50-55% med en batch-størrelse på ca. 10 mol.Although the last described process is actually more economical than the former, some difficulties arise when applied at the factory level. The water formed by the condensation reaction of 3,4,5-trimethoxybenzaldehyde and β - (2-alkoxyethoxy) propionitrile is distilled off at high temperature, e.g. ca. 120 ° C. At such a high temperature, the α- (3,4,5-trimethoxybenzal) -β- (2-alkoxyethoxy) propionitrile is hydrolyzed by the water present. It has now been found, according to the invention, that the hydrolysis of the nitrile group takes place as a parallel reaction and the corresponding carboxylic acid is prepared. In this reaction, tar-like byproducts are formed. The amount thereof is increased by the use of larger batch quantities. Thus, the total yield obtained from the laboratory scale of 64-72% becomes as low as 50-55% with a batch size of approx. 10 mol.

Som følge heraf er den i GB patentskrift nr.As a result, in GB patent no.

35 1.554.493 beskrevne fremgangsmåde ikke tilstrækkeligt økonomisk til industriel anvendelse.35 1,554,493 discloses not sufficiently economical for industrial use.

3 DK 155668B3 DK 155668B

OISLAND

Formålet med den foreliggende opfindelse er at tilvejebringe en økonomisk industrielt anvendelig fremgangsmåde til fremstilling af 2,4-diamino-5-(3',41,5'--trimethoxybenzyl)-pyrimidin.The object of the present invention is to provide an economically industrially useful process for the preparation of 2,4-diamino-5- (3 ', 41,5' - trimethoxybenzyl) pyrimidine.

5 Det har ifølge opfindelsen vist sig, at såfremt a-(3,4,5-trimethoxybenzal)-β-methoxypropionitril med formlen CH-0 3 \According to the invention, it has been found that if α- (3,4,5-trimethoxybenzal) -β-methoxypropionitrile of the formula CH-O 3

X___ CNX___ CN

10 CH O-/ \-CH=C (XII) V-/ iH2-OCH3 CHjø/ omsættes med en diethylenglycol-monoalkylether med form-15 len ho-ch2ch2-o-ch2ch2-or (IV) hvor R er en alkylgruppe med 1-4 carbonatomer, isomerise-rer "benzal"-isomeren med formlen CH3°‘CH 2 - / - -CH = C (XII) V- / 1H 2 -OCH 3 CH 2 / reacted with a diethylene glycol monoalkyl ether of the formula ho-ch2ch2-o-ch2ch2 or (IV) wherein R is an alkyl group having 1-4 carbon atoms, the "benzal" isomer of the formula CH 3

20 \_. CN20 \ _. CN

CH30-/ \-CH=C (Ila)CH30- / \ -CH = C (IIa)

_// CH2-0-CH2CH2-0-CH2CH2-0R_ // CH2-0-CH2CH2-0-CH2CH2-0R

αΗ3οκ 25 hvor R har den ovenfor anførte betydning, og som er fremstillet i teoretisk udbytte, til den tilsvarende "benzyl"--isomer med formlen CHo0 3 \αΗ3οκ 25 where R has the meaning given above, and is prepared in theoretical yield, for the corresponding "benzyl" isomer of the formula CH

\_ CN\ _ CN

/--\ i 30 CH30-./ \-CH2-C (II) V_y c!h-o-ch2ch2-o-ch2ch2-or hvor R har den ovenfor anførte betydning, allerede ved så lav en temperatur som 60-90°C og i næsten teoretisk udbytte./ - \ in 30 CH30-./ \ -CH2-C (II) V-carbonyl-ch2ch2-o-ch2ch2-or where R has the meaning given above, already at a temperature as low as 60-90 ° C and in almost theoretical yield.

35 435 4

OISLAND

DK 155668BDK 155668B

Den således fremstillede "benzyl"-isomer er af en sådan renhed, at den - eventuelt uden fraskillelse og rensning -kan cycliseres med guanidin til dannelse af trimethoprim.The "benzyl" isomer thus prepared is of such purity that it - optionally without separation and purification - can be cyclized with guanidine to form trimethoprim.

Ifølge den foreliggende opfindelse fremstilles 5 2,4-diamino-5-(3',41,5'-trimethoxybenzyl)-pyrimidin med formlen (I) ved omsætning af en a-(3,4,5-trimethoxybenzyl )-β-(substitueret)acrylonitril med guanidin, hvor en a-(3,4,5-trimethoxybenzal)-β-methoxypropionitril med formlen (III) omsættes med en diethylenglycol-monoalkyl-10 ether med formlen (IV) ved 60-90°C i nærværelse af et alkalimetalalkoxid, og den fremstillede benzylisomer med formlen (II) omsættes - eventuelt uden fraskillelse -med guanidin i nærværelse af en alkanol med 4-8 carbon-atomer.According to the present invention, 5,4-diamino-5- (3 ', 41,5'-trimethoxybenzyl) pyrimidine of formula (I) is prepared by reacting an α- (3,4,5-trimethoxybenzyl) -β- (substituted) acrylonitrile with guanidine, wherein an α- (3,4,5-trimethoxybenzal) -β-methoxypropionitrile of formula (III) is reacted with a diethylene glycol monoalkyl ether of formula (IV) at 60-90 ° C. in the presence of an alkali metal alkoxide, and the benzyl isomer of formula (II) prepared is reacted - optionally without separation - with guanidine in the presence of an alkanol of 4-8 carbon atoms.

15 Som forbindelsen med formlen (IV) anvendes for trinsvis diethylenglycol-monomethylether. Denne forbindelse anvendes almindeligvis i overskud, og i dette tilfælde kræves der ikke noget særskilt opløsningsmiddel.As the compound of formula (IV) is used for stepwise diethylene glycol monomethyl ether. This compound is commonly used in excess, and in this case no separate solvent is required.

Som alkalimetalalkoxid anvendes fortrinsvis 20 natriummethoxid, natriumethoxid, kaliummethoxid etc.As the alkali metal alkoxide, sodium methoxide, sodium ethoxide, potassium methoxide, etc. are preferably used.

"Benzyl"-isomeren med formlen (II) samt "benzal"--isomeren med formlen (Ila) er hidtil ukendte forbindelser. "Benzal"-isomeren behøver ikke at isoleres, og ved fremgangsmåden ifølge opfindelsen omdannes den kvantita-25 tivt til "benzyl"-isomeren på almindeligvis 1-2 timer. Den dannede "benzyl"-isomer kan isoleres, men om ønsket cycliseres den med guanidin uden isolering.The "benzyl" isomer of formula (II) as well as the "benzal" isomer of formula (IIa) are novel compounds. The "benzal" isomer need not be isolated, and in the process of the invention it is quantitatively converted to the "benzyl" isomer in usually 1-2 hours. The "benzyl" isomer formed can be isolated, but if desired, it is cyclized with guanidine without isolation.

"Benzyl"-isomeren med formlen (II) cycliseres med guanidin, fortrinsvis±nærværelse af en alkanol med 30 4-8 carbonatomer, såsom en tertiær butanol eller isobutan- ol. Naturligvis kan der også være andre organiske opløsningsmidler til stede i ringslutningsreaktionen, f.eks. en yderligere alkanol, såsom methanol.The "benzyl" isomer of formula (II) is cyclized with guanidine, preferably ± the presence of an alkanol having from 4 to 8 carbon atoms, such as a tertiary butanol or isobutanol. Of course, other organic solvents may also be present in the cyclization reaction, e.g. a further alkanol such as methanol.

Såfremt forbindelsen med formlen (II) ikke isoleres 35 før ringslutningen med guanidin, er der også et vilkårligtIf the compound of formula (II) is not isolated before the cyclization with guanidine, there is also any

DK 155668BDK 155668B

5 o overskud af den i den forudgående omsætning anvendte diethylenglycol-monoalkylether med formlen (IV) til stede i ringslutningen.An excess of the diethylene glycol monoalkyl ether of formula (IV) used in the preceding reaction is present in the cyclization.

Guanidin anvendes fortrinsvis som et syreaddi-5 tionssalt, såsom hydrochlorid. I dette tilfælde frigøres guanidin fra syreadditionssaltet i reaktionsblandingen med en base, der passende kan være alkali-metalalkoxid.Guanidine is preferably used as an acid addition salt such as hydrochloride. In this case, guanidine is released from the acid addition salt in the reaction mixture with a base which may conveniently be alkali metal alkoxide.

Ringslutningen af "benzyl"-isomeren gennemføres 10 almindeligvis ved 70-100°C, især ved reaktionsblandingens kogepunkt.The cyclization of the "benzyl" isomer is generally carried out at 70-100 ° C, especially at the boiling point of the reaction mixture.

Den som udgangsstof anvendte a-(3,4,5-trimeth-oxybenzal)-β-methoxy-propionitril med formlen (III) er fremstillet ud fra 3,4,5-trimethoxybenzaldehyd med 15 β-methoxy-propionitril. Sidstnævnte forbindelse er fremstillet ved omsætning af acrylonitril med methanol i alkalisk medium.The α- (3,4,5-trimethoxy-benzal) -β-methoxy-propionitrile of formula (III) used as the starting material is prepared from 3,4,5-trimethoxy-benzaldehyde with 15-β-methoxy-propionitrile. The latter compound is prepared by reaction of acrylonitrile with methanol in alkaline medium.

Den her omhandlede fremgangsmåde tillader en økonomisk fremstilling af trimethoprim. Det samlede ud-20 bytte, beregnet for 3,4,5-trimethoxybenzaldehyd, som er ca. 80%, påvirkes ikke i ugunstig retning ved anvendelse af større batch-mængder. Trimethoprim med meget høj renhedsgrad, som er egnet til farmaceutiske formål, fremstilles ud fra forbindelsen med formlen (III) i et 25 enkelt trin.The process of the present invention allows the economical preparation of trimethoprim. The total yield, calculated for 3,4,5-trimethoxybenzaldehyde, which is approx. 80%, is not adversely affected by the use of larger batches. Very high purity trimethoprim suitable for pharmaceutical purposes are prepared from the compound of formula (III) in a single step.

Opfindelsen belyses nærmere i de efterfølgende eksempler.The invention is further illustrated in the following examples.

Fremstilling af udgangsforbindelsen.Preparation of the starting compound.

1,75 g Kaliumhydroxid opløses i 115 ml methanol 30 i en 4 liter-kolbe. Der sættes 55 g acrylonitril til opløsningen i løbet af 20 minutter og under afkøling for at undgå temperaturer over 40°C. Reaktionsblandingen omrøres ved 40°C i 1 time, hvorpå der tilsættes 100 g 3,4,5-trimethoxybenzaldehyd. Blandingen opvarmes til 60°C 35 og omrøres i 8 timer ved denne temperatur, hvorefterDissolve 1.75 g of potassium hydroxide in 115 ml of methanol in a 4 liter flask. 55 g of acrylonitrile is added to the solution over 20 minutes and under cooling to avoid temperatures above 40 ° C. The reaction mixture is stirred at 40 ° C for 1 hour, then 100 g of 3,4,5-trimethoxybenzaldehyde is added. The mixture is heated to 60 ° C and stirred for 8 hours at this temperature, after which

OISLAND

s DK 155668Bs DK 155668B

der afkøles til 30°C. Der tilsættes 55 ml methanol og 30 g kaliumhydroxid/ sidstnævnte i flere portioner.cool to 30 ° C. 55 ml of methanol and 30 g of potassium hydroxide / the latter are added in several portions.

Den dannede suspension omrøres i 5 timer, afkøles derpå til 20°C og tilsættes 500 ml vand i løbet af 15 minut-5 ter. Produktet krystalliseres ved 5-lO°C, filtreres, vaskes med 3 portioner på hver 15 ml methanol og 3 portioner på hver 100 ml vand, hvorpå der tørres.The resulting suspension is stirred for 5 hours, then cooled to 20 ° C and 500 ml of water is added over 15 minutes. The product is crystallized at 5-10 ° C, filtered, washed with 3 portions on each 15 ml of methanol and 3 portions on each 100 ml of water, and then dried.

Der fås 116 g (86%) a-(3,4,5-trimethoxybenzal)--β-methoxy-propionitril, smp. 81-83°C.116 g (86%) of α- (3,4,5-trimethoxybenzal) - β-methoxy-propionitrile, m.p. 81-83 ° C.

10 Eksempel 1 120 ml vandfri diethylenglycol-monomethylether, 100 g (0,38 mol) a-(3,4,5-trimethoxybenzal)-β-methoxy-propionitril og 5 g pulveriseret natriummethoxid sættes til en 1 liter kolbe. Reaktionsblandingen opvarmes til 15 74-76°C, omrøres i 3 timer ved denne temperatur og afkøles derpå til 30°C. Der tilsættes 160 ml isobutanol, 40 ml methanol, 85 g guanidin-hydrochlorid og 50 g pulveriseret natriummethoxid. Blandingen omrøres ved 35-40°C i 1 time, opvarmes derpå til 90-92°C og omrøres i 7 timer 20 ved blandingens kogepunkt. Den dannede suspension afkøles til under 20°C, filtreres derpå, vaskes med 3 portioner på hver 20 ml methanol, derpå med 500 ml vand ved 30-35°C og tørres.Example 1 120 ml of anhydrous diethylene glycol monomethyl ether, 100 g (0.38 mol) of α- (3,4,5-trimethoxybenzal) -β-methoxy-propionitrile and 5 g of powdered sodium methoxide are added to a 1 liter flask. The reaction mixture is heated to 74-76 ° C, stirred for 3 hours at this temperature and then cooled to 30 ° C. 160 ml of isobutanol, 40 ml of methanol, 85 g of guanidine hydrochloride and 50 g of powdered sodium methoxide are added. The mixture is stirred at 35-40 ° C for 1 hour, then heated to 90-92 ° C and stirred for 7 hours at the boiling point of the mixture. The resulting suspension is cooled to below 20 ° C, then filtered, washed with 3 portions of each 20 ml of methanol, then with 500 ml of water at 30-35 ° C and dried.

Der fås 102 g (93%) 2,4-diamino-5-(3',41,5'-tri-25 methoxybenzyl)-pyrimidin, smp. 198-201°C.102 g (93%) of 2,4-diamino-5- (3 ', 41,5'-trimethoxybenzyl) pyrimidine, m.p. 198-201 ° C.

Eksempel 2 A. a-(3,4,5-Trimethoxybenzyl)-β-[2-(2'-methoxy- ethoxy)-ethoxy]-acrylonitril.Example 2 A. α- (3,4,5-Trimethoxybenzyl) -β- [2- (2'-methoxyethoxy) -ethoxy] -acrylonitrile.

En blanding af 120 ml vandfri diethylenglycol-30 -monomethylether, 100 g a-(3,4,5-trimethoxybenzal)-^-methoxypropionitril og 5 g natriummethoxid opvarmes til 74-76°C i 3 timer, hvorpå der afkøles til 20°C. Blandingen hældes i en blanding af 300 ml benzen og 500 ml vand.A mixture of 120 ml of anhydrous diethylene glycol-30-monomethyl ether, 100 g of α- (3,4,5-trimethoxybenzal) - methoxypropionitrile and 5 g of sodium methoxide is heated to 74-76 ° C for 3 hours, then cooled to 20 °. C. The mixture is poured into a mixture of 300 ml of benzene and 500 ml of water.

Den organiske fase skilles fra, vaskes med 2 portioner på 35 hver 200 ml vand og inddampes. Det som remanens fremkomneThe organic phase is separated, washed with 2 portions of 35 each 200 ml of water and evaporated. It as the residue emerged

7 DK 155668B7 DK 155668B

OISLAND

110 g råprodukt renses ved destillation. Den rene forbindelse "har et kogepunkt på 208-214°C ved 0,02 mm Hg.110 g of crude product is purified by distillation. The pure compound "has a boiling point of 208-214 ° C at 0.02 mm Hg.

B. 2,4-Diamino-5-(31,4',51-trimethoxybenzyl)- -pyrimidin.B. 2,4-Diamino-5- (31,4 ', 51-trimethoxybenzyl) -pyrimidine.

5 Til en blanding af 200 ml isobutanol, 80 ml meth anol, 190 g guanidin-hydrochlorid og 100 g natriummeth-oxid sættes 200 g a-(3,4,5-trimethoxybenzyl)-β-[2-(meth-oxyethoxy)-ethoxy]-acrylonitril opløst i 120 ml isobutanol. Reaktionsblandingen opvarmes og koges under til-10 bagesvaling i 7 timer, hvorpå der afkøles til 20°C. Det krystallinske produkt filtreres, vaskes med 3 portioner på hver 20 ml methanol, suspenderes derpå i 500 ml vand, filtreres, vaskes med vand og tørres.To a mixture of 200 ml of isobutanol, 80 ml of meth anol, 190 g of guanidine hydrochloride and 100 g of sodium methoxide are added 200 g of α- (3,4,5-trimethoxybenzyl) -β- [2- (methoxyoxy) -ethoxy] -acrylonitrile dissolved in 120 ml of isobutanol. The reaction mixture is heated and refluxed for 7 hours, then cooled to 20 ° C. The crystalline product is filtered, washed with 3 portions of each 20 ml of methanol, then suspended in 500 ml of water, filtered, washed with water and dried.

Der fås 174,5 g (95%) 2,4-diamino-5-(3',41,5'-15 -trimethoxybenzyl)-pyrimidin, smp. 198-201°C.174.5 g (95%) of 2,4-diamino-5- (3 ', 41,5'-15-trimethoxybenzyl) pyrimidine, m.p. 198-201 ° C.

Eksempel 3Example 3

En blanding af 350 kg vandfri diethylenglycol--monomethylether, 300 kg a-(3,4,5-trimethoxybenzal)-β--methoxypropionitril og 20 kg pulveriseret natrium-20 methoxid opvarmes til 78-80°C i 4 timer. Blandingen afkøles til 30°C, og der tilsættes 540 1 isobutanol, 120 1 methanol, 275 kg guanidin-hydrochlorid og 160 kg pulveriseret natriummethoxid. Reaktionsblandingen omrøres ved 35-40°C i 1 time og derpå ved 90-92°C i 7 timer under 25 tilbagesvaling. Den dannede suspension afkøles til 20°C, centrifugeres og vaskes med 200 1 methanol. Det dannede våde produkt suspenderes i 1500 1 vand ved 30-35°C, centrifugeres, vaskes med 500 1 vand og tørres.A mixture of 350 kg of anhydrous diethylene glycol - monomethyl ether, 300 kg of α- (3,4,5-trimethoxybenzal) -β-methoxypropionitrile and 20 kg of powdered sodium methoxide is heated to 78-80 ° C for 4 hours. The mixture is cooled to 30 ° C and 540 l of isobutanol, 120 l of methanol, 275 kg of guanidine hydrochloride and 160 kg of powdered sodium methoxide are added. The reaction mixture is stirred at 35-40 ° C for 1 hour and then at 90-92 ° C for 7 hours under reflux. The resulting suspension is cooled to 20 ° C, centrifuged and washed with 200 liters of methanol. The resulting wet product is suspended in 1500 L of water at 30-35 ° C, centrifuged, washed with 500 L of water and dried.

Der fås 300 kg (91%) 2,4-diamino-5-(31,41,51-tri-30 methoxybenzyl)-pyrimidin, smp. 198-201°C.300 kg (91%) of 2,4-diamino-5- (31,41,51-trimethoxybenzyl) pyrimidine, m.p. 198-201 ° C.

3535

Claims (4)

1. Fremgangsmåde til fremstilling af 2,4-diamino--5-(3',41,51-trimethoxybenzyl)-pyrimidin med formlen CH-0 NEL· 3 \ \2 5 /~N\ CH-O- / V. -NEL· (I) 3 \.// 2 W /* CH30' 10 ved omsætning'af en a-(3,4,5-trimethoxybenzyl)-β-(substitueret) acrylonitril med guanidin, kendetegnet ved, at en a-(3,4,5-trimethoxybenzal)-β-methoxypropio-nitril med formlen CH3° 15 \___ CN / \ 1 CH-O-/. .-CH=C (III) __V CH2-OCH3 ch3o' 20 omsættes med en diethylenglycol-monoalkylether med formlen ho-ch2ch2-o-ch2ch2-or (IV) hvor R er en alkylgruppe med 1-4 carbonatomer, ved 60-90°C i nærværelse af et alkalimetalalkoxid, og den fremkomne 25 benzylisomer med formlen CH_0 3 \ \__.. CN / \ I CH-O-/ >-CH„-C (II) 3 \\ // 2 II CH-0-CH2CH2-0-CH2CH2-0RA process for the preparation of 2,4-diamino-5- (3 ', 41,51-trimethoxybenzyl) -pyrimidine of the formula CH-0 NEL · 3 \ \ 2 5 / ~ N \ CH-O- / V. -NEL · (I) 3 \ .// 2 W / * CH30 '10 by reaction of an α- (3,4,5-trimethoxybenzyl) -β- (substituted) acrylonitrile with guanidine, characterized in that an - (3,4,5-trimethoxybenzal) -β-methoxypropionitrile of the formula CH3 ° 15 \ ___ CN / \ 1 CH-O- /. -CH = C (III) VV CH 2 -OCH 3 CH 3 O 20 is reacted with a diethylene glycol monoalkyl ether of the formula ho-CH 2 CH 2 -O-CH 2 CH 2 -or (IV) wherein R is an alkyl group of 1-4 carbon atoms, at 60-90 ° C in the presence of an alkali metal alkoxide and the resulting benzyl isomer of the formula CH_O 3 \ \ __ .. CN / \ I CH-O- /> -CH 2 -C (II) 3 \\ // 2 II CH-0 -CH2CH2-0-CH2CH2-0R 30 CH30 hvor R har den ovenfor anførte betydning, omsættes - eventuelt uden isolering - med guanidin i nærværelse af en alkanol med 4-8 carbonatomer. 35Where R has the meaning given above, it is reacted - optionally without isolation - with guanidine in the presence of an alkanol of 4-8 carbon atoms. 35 9 DK 155668 B o9 DK 155668 B o 2. Fremgangsmåde ifølge krav 1, kendetegnet ved, at diethylenglycol-monoalkyletheren er di-ethylenglycol-monomethylether.Process according to claim 1, characterized in that the diethylene glycol monoalkyl ether is diethylene glycol monomethyl ether. 3. Fremgangsmåde ifølge krav 1 eller 2, k e n - 5 detegnet ved, at alkalimetalalkoxidet er natrium-methoxid.A process according to claim 1 or 2, characterized in that the alkali metal alkoxide is sodium methoxide. 4. Fremgangsmåde ifølge et hvilket som helst af kravene 1-3, kendetegnet ved, at omsætningen af a-(3,4,5-trimethoxybenzal)-|3-methoxypropionitrilen med 10 formlen (III) med diethylenglycol-monomethyletheren gennemføres ved 70-80°C. 15 20 25 30 35Process according to any one of claims 1-3, characterized in that the reaction of the α- (3,4,5-trimethoxybenzal) -β-methoxypropionitrile of formula (III) with the diethylene glycol monomethyl ether is carried out at 70 80 ° C. 15 20 25 30 35
DK275682A 1981-06-26 1982-06-18 METHOD FOR PREPARING 2,4-DIAMINO-5- (3 ', 4', 5'-TRIMETHOXYBENZYL) -PYRIMIDINE DK155668C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU811868A HU186413B (en) 1981-06-26 1981-06-26 Process for producing 2,4-diamino-5-bracket-3-comma above,4-comma above,5-comma above-trimethoxy-benzyl-bracket closed-pyrimidine
HU186881 1981-06-26

Publications (3)

Publication Number Publication Date
DK275682A DK275682A (en) 1982-12-27
DK155668B true DK155668B (en) 1989-05-01
DK155668C DK155668C (en) 1989-09-18

Family

ID=10956590

Family Applications (1)

Application Number Title Priority Date Filing Date
DK275682A DK155668C (en) 1981-06-26 1982-06-18 METHOD FOR PREPARING 2,4-DIAMINO-5- (3 ', 4', 5'-TRIMETHOXYBENZYL) -PYRIMIDINE

Country Status (22)

Country Link
JP (1) JPS5838265A (en)
AT (1) AT385033B (en)
AU (1) AU547822B2 (en)
BE (1) BE893609A (en)
CA (1) CA1164458A (en)
CH (1) CH651828A5 (en)
CS (1) CS244907B2 (en)
DD (1) DD202702A5 (en)
DK (1) DK155668C (en)
ES (1) ES513481A0 (en)
FI (1) FI76789C (en)
FR (1) FR2508449B1 (en)
GB (1) GB2106098B (en)
GR (1) GR76158B (en)
HU (1) HU186413B (en)
IE (1) IE53347B1 (en)
IL (1) IL66131A (en)
IT (1) IT1190888B (en)
RO (1) RO85316B (en)
SE (1) SE451134B (en)
SU (1) SU1147252A3 (en)
YU (1) YU42264B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1303727B (en) * 1959-09-03 1976-02-05 Ausscheidung aus: 14 45 176 The Wellcome Foundation Ltd., London Alpha-arylidene-substituted propioni-iriles
NL122146C (en) * 1960-09-02
DE2635765C3 (en) * 1976-08-09 1979-02-08 Ludwig Heumann & Co Gmbh, 8500 Nuernberg Process for the preparation of 2,4-EMamino-5- (3 ', 4'r5'-trimethoxybenzyl) -pyrimidine
US4115650A (en) * 1976-11-17 1978-09-19 Hoffmann-La Roche Inc. Process for preparing 2,4-diamino-5-(substituted benzyl)-pyrimidines
DE2730467A1 (en) * 1977-07-06 1979-01-18 Basf Ag BENZYLPYRIMIDINE, METHOD FOR THE PRODUCTION THEREOF, AND MEDICINAL PRODUCTS CONTAINING THE SAME

Also Published As

Publication number Publication date
IL66131A0 (en) 1982-09-30
ATA244882A (en) 1987-07-15
FI822267A0 (en) 1982-06-24
IT1190888B (en) 1988-02-24
CS244907B2 (en) 1986-08-14
SE8203913D0 (en) 1982-06-23
SU1147252A3 (en) 1985-03-23
FR2508449B1 (en) 1986-01-10
FR2508449A1 (en) 1982-12-31
BE893609A (en) 1982-12-23
FI822267L (en) 1982-12-27
SE451134B (en) 1987-09-07
FI76789B (en) 1988-08-31
ES8304948A1 (en) 1983-04-01
IT8222034A0 (en) 1982-06-24
AT385033B (en) 1988-02-10
GB2106098B (en) 1984-12-19
IE53347B1 (en) 1988-10-26
FI76789C (en) 1988-12-12
GR76158B (en) 1984-08-03
CH651828A5 (en) 1985-10-15
IL66131A (en) 1985-03-31
AU8534582A (en) 1983-01-06
ES513481A0 (en) 1983-04-01
IE821521L (en) 1982-12-20
HU186413B (en) 1985-07-29
DD202702A5 (en) 1983-09-28
DK155668C (en) 1989-09-18
YU42264B (en) 1988-06-30
GB2106098A (en) 1983-04-07
YU138482A (en) 1984-10-31
CS471682A2 (en) 1985-09-17
AU547822B2 (en) 1985-11-07
JPS5838265A (en) 1983-03-05
RO85316A (en) 1984-09-29
DK275682A (en) 1982-12-27
RO85316B (en) 1984-10-30
SE8203913L (en) 1982-12-27
CA1164458A (en) 1984-03-27

Similar Documents

Publication Publication Date Title
NO115741B (en)
US3697512A (en) 5-benzyl pyrimidines intermediates
KR20080023730A (en) New pyrocatechin derivatives
US3855265A (en) 5-benzyl pyrimidines intermediates therefore, and method
DK155668B (en) METHOD FOR PREPARING 2,4-DIAMINO-5- (3 ', 4', 5'-TRIMETHOXYBENZYL) -PYRIMIDINE
US4029662A (en) Method of making barbituric acid derivatives
US4216319A (en) Synthesis of 2,4-diamino-5-benzylpyrimidines using benzyl cyanoacetal intermediates
US2679501A (en) Amino derivatives of 2-substituted-4-tert. butylphenol ethers
US5294710A (en) N-5-protected 2,5-diamino-4,6-dichloropyrimidines and process for their production
KR100233068B1 (en) Process for the preparation of 2-substituted 4,6-dialkoxypyrimidine
US3878252A (en) Ring substituted beta-hydroxy-phenyethylmethyl sulphone or sulphoxide
KR20170108080A (en) Methods for the preparation of compounds such as 3-arylbutanal which are useful in the synthesis of medetomidine
Russell et al. α-Aryl-β-alkyloxyacrylonitriles
CA1071627A (en) Pyrimidine derivatives
DK155434B (en) METHOD FOR PREPARING 2,4-DIAMINO-5- (3 ', 4', 5'-TRIMETHOXYBENZYL) PYRIMIDINE
US4568744A (en) Benzylpyrimidine synthesis and intermediates
AU627561B2 (en) New process for the synthesis of the n-methyl-3,4- dimethoxyphenylethylamine
US6166259A (en) Process for preparing a 1,1,1-trifluoro-2-aminoalkane
US2447465A (en) 6-(alpha-ethylpropyl)-2-thiouracil and preparation of the same
HU193617B (en) Process for producing 2-/dialkoxy-methyl/-3,3-dialkoxy-propane-nitril derivatives
KR800001048B1 (en) Process for preparing-4-hydroxy methyl-2-pyrroli-dinones
EP0001633A1 (en) Processes for preparing tri-heterocyclic substituted methanes and their conversion into further intermediates useful in the preparation of pharmacologically active compounds
SK283285B6 (en) Process for the preparation of substituted pyrimidines
JPS5993061A (en) Manufacture of 2,4-diamino-5-benzylpyrimidine derivative
NO141405B (en) PROCEDURES FOR THE PREPARATION OF N-SUBSTITUTED BETA-AMINO-ALFA-BENZYLACRYLONITRILES

Legal Events

Date Code Title Description
PBP Patent lapsed